{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:42:34Z","timestamp":1761662554822},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.2165\/00002018-199717050-00003","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T05:42:51Z","timestamp":1196833371000},"page":"303-316","source":"Crossref","is-referenced-by-count":13,"title":["A Risk-Benefit Assessment of Growth Hormone Use in Children"],"prefix":"10.2165","volume":"17","author":[{"given":"Sandra L.","family":"Blethen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret H.","family":"MacGillivray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T09:22:05Z","timestamp":1455009725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199717050-00003"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199717050-00003","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}